Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-16-120777
Filing Date
2016-08-23
Accepted
2016-08-23 16:41:14
Documents
1
Period of Report
2016-08-19

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v447459_3.html 3  
1 OWNERSHIP DOCUMENT v447459_3.xml 3 1555
  Complete submission text file 0001144204-16-120777.txt   2936
Mailing Address 2450 SOUTH SHORE BLVD. SUITE 402 LEAGUE CITY TX 77573
Business Address
Foster Jonathan P. (Reporting) CIK: 0001545414 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37758 | Film No.: 161847550

Mailing Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054
Business Address 2575 WEST BELLFORT SUITE 333 HOUSTON TX 77054 713-300-5160
Moleculin Biotech, Inc. (Issuer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations